State Of Tennessee, Treasury Department Adaptimmune Therapeutics PLC Transaction History

State Of Tennessee, Treasury Department

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 15, 2023	BUY	$1.05 - $2.53 $13,755 - $33,143	13,100 New	13,100 $19,000
Q1 2021 May 10, 2021	SELL	$4.9 - $6.83 $231,476 - $322,649	-47,240 Closed	0 $0
Q4 2020 Feb 09, 2021	BUY	$4.0 - $9.2 $188,960 - $434,607	47,240 New	47,240 $255,000
Q3 2019 Oct 30, 2019	SELL	$1.43 - $3.81 $8,701 - $23,183	-6,085 Closed	0 $0
Q4 2018 Feb 11, 2019	BUY	$3.76 - $14.16 $22,879 - $86,163	6,085 New	6,085 $35,000

152M

78.5K

36.5K

Ticker ADAP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 163,370,000
Market Cap $121M
Description
Adaptimmune Therapeutics plc, a clinical-stage biopharmaceutical company, focuses on providing novel cell therapies primarily to patients with solid tumors in the United States and the United Kingdom. The company's specific peptide enhanced affinity receptor (SPEAR) T-cell platform enables it to identify cancer targets. It is developing ADP-A2M4...

Get notified when there are updates to the investment portfolio of State Of Tennessee, Treasury Department, based on Form 13F filings with the SEC.

Stay updated on State Of Tennessee, Treasury Department with notifications on news.